![]() |
|
|
Vol. 294, Issue 3, 1219-1224, September 2000
Program in Cell Signaling, Institute of Molecular Medicine and
Genetics, Medical College of Georgia, Augusta, Georgia
Inhibitors of sphingolipid metabolism are frequently used to
investigate the role of ceramide and other sphingolipids as
intracellular signaling molecules. For example, the inhibitor of
glucosylceramide synthase
D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) is commonly used to deplete glycosphingolipids and increase ceramide levels. Ceramide is known to induce growth arrest and differentiation of keratinocytes, and we hypothesized that PDMP would
increase ceramide levels and induce growth arrest of primary cultures
of mouse epidermal keratinocytes. As expected, PDMP increased ceramide
levels and decreased the incorporation of [3H]thymidine
into DNA, but surprisingly, PDMP was found to rapidly inhibit the
intracellular transport of [3H]thymidine. This is likely
due to a direct effect on nucleoside transport by PDMP and not due to
elevations in ceramide levels because increasing ceramide levels by the
addition of exogenous sphingomyelinase had no effect on
[3H]thymidine transport. Furthermore, it is unlikely that
the decreased [3H]thymidine transport is in response to
growth arrest because PDMP had no effect on the cell cycle profile of
keratinocytes. These results reveal that PDMP inhibits nucleoside
transport independent of effects on ceramide levels or cell growth but
probably by a direct effect on the nucleoside transport apparatus.
Thus, this compound may be unsuitable for investigating the role of
ceramide or other sphingolipids in some cellular processes.
This article has been cited by other articles:
![]() |
T. Sprocati, P. Ronchi, A. Raimondi, M. Francolini, and N. Borgese Dynamic and reversible restructuring of the ER induced by PDMP in cultured cells J. Cell Sci., August 1, 2006; 119(15): 3249 - 3260. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Davis, D. A. Thompson, L. L. Howard, C. Morisseau, B. D. Hammock, and R. H. Weiss Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation PNAS, February 6, 2002; (2002) 261710799. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Davis, D. A. Thompson, L. L. Howard, C. Morisseau, B. D. Hammock, and R. H. Weiss Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation PNAS, February 19, 2002; 99(4): 2222 - 2227. [Abstract] [Full Text] [PDF] |
||||